EUVIMEDEUVIMED entdecken
Multizentrische Studie

Identification of phenotypes in thrombotic primary antiphospholipid syndrome using cluster analysis: a step toward personalized medicine

Gabrielle M Santos, Paula David, Or Hen, Juan Luis Ontiveros-Austria, Rotem Liran, Sergio Rodriguez-Rodriguez, Julia Cerchiari de Godói, Yonatan Shneor Patt, Shaked Beladev, Erica Okazaki, Marina Collela, Bianca Stefanello und 15 weitere

Journal of Thrombosis and Haemostasis · 2025

DOI: 10.1016/j.jtha.2025.06.010 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Gabrielle M Santos und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Hemotherapy and Cellular Therapy, Hospital das Clínicas of University of São Paulo Medical School (HCFMUSP), São Paulo, Bra…. Hauptthemen laut MEDLINE: Antiphospholipid Syndrome, Precision Medicine, Thrombosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: State of Sao Paulo Research Foundation, Coordination of Higher Education Personnel Improvement, Ministério da Ciência, Tecnologia, Inovações e Comunicações.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Thrombotic risk in primary antiphospholipid syndrome (APS) is a result of complex, yet undefined, interactions among multiple factors. While long-term anticoagulation reduces thrombotic complications, its efficacy varies, with thrombosis recurrence rates ranging from 5% to 20% within 2 years. Emerging therapies may benefit specific APS subgroups, although identifying and stratifying these groups remains a significant challenge. OBJECTIVES: To identify specific phenotypic subgroups of thrombotic primary APS based on clinical and laboratory characteristics to provide insight for both personalized diagnostic and therapeutic strategies. METHODS: Multicenter retrospective cohort study including 663 patients with thrombotic primary APS who were followed in Brazil, Israel, and Mexico (2018-2023). Hierarchical cluster analysis categorized patients based on demographics, thrombotic characteristics, comorbidities, and laboratory data. RESULTS: Cluster analysis identified 3 distinct phenotypes. Cluster 1 (n = 348) included older patients (median age 43 years) with high cardiovascular risk factors (hypertension, diabetes, and dyslipidemia) and predominantly arterial thrombosis (53%, P < .001). Cluster 2 (n = 119) included younger patients (median age 35 years) with high recurrence rates (71%, P < .001) of venous thromboembolism (80%, P < .001) and higher anticardiolipin prevalence (29%, P < .001). Cluster 3 (n = 196) featured the youngest patients (median age 29 years), predominantly triple antiphospholipid antibody positive (98.5%, P < .001), with complement consumption (C3: 17%, P = .003), thrombocytopenia (12%, P = .05), and venous thrombosis (73%, P < .001). CONCLUSION: This study identified 3 distinct phenotypes of thrombotic primary APS, each characterized by the predominance of cardiovascular risk factors, hypercoagulability, or immunologic derangements. The findings provide a basis for developing personalized management strategies to improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiphospholipid SyndromePrecision MedicineThrombosisHumansFemaleAdultMaleRetrospective StudiesPhenotypeMiddle AgedCluster AnalysisRisk FactorsMexicoRecurrenceIsraelBrazilYoung AdultRisk Assessment

Stichwörter der Autor:innen

antiphospholipid syndromeautoantibodiesindividualized medicinerisk factorsthrombosis

Autor:innen und Institutionen

  • Department of Hematology, Hemotherapy and Cellular Therapy, Hospital das Clínicas of University of São Paulo Medical School (HCFMUSP), São Paulo, Brazil; State Institute of Hematology Arthur de Siqueira Cavalcanti (HEMO…
  • Department of Medicine 'B,' Sheba Medical Center, Tel Hashomer, Israel; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; Department of Medicine 'C,' Sheba Medical Center, Tel Ha…
  • Department of Medicine 'C,' Sheba Medical Center, Tel Hashomer, Israel; Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Department of Hematology and Oncology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
  • Department of Internal Medicine E, Meir Medical Center, Kfar Saba, Israel and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • School of Medical Sciences, University of Campinas, Campinas, SP, Brazil.

Förderung

  • State of Sao Paulo Research Foundation
  • Coordination of Higher Education Personnel Improvement
  • Ministério da Ciência, Tecnologia, Inovações e Comunicações
  • Universidade Estadual de Campinas
  • State University of Campinas Teaching Research and Extension Support Fund
  • National Council for Scientific and Technological Development

Zitieren

APA

Santos, G. M., David, P., Hen, O., Ontiveros-Austria, J. L., Liran, R., Rodriguez-Rodriguez, S., Cerchiari de Godói, J., Patt, Y. S., Beladev, S., Okazaki, E., Collela, M., Stefanello, B., Yamaguti-Hayakawa, G. G., Rothschild, C., Annichino-Bizzachi, J., Vargas-Ruiz, A., Prestes, P., Rocha, V., de Paula, E. V., …, & Orsi, F. A. (2025). Identification of phenotypes in thrombotic primary antiphospholipid syndrome using cluster analysis: a step toward personalized medicine. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.06.010

Vancouver

Santos GM, David P, Hen O, Ontiveros-Austria JL, Liran R, Rodriguez-Rodriguez S, et al. Identification of phenotypes in thrombotic primary antiphospholipid syndrome using cluster analysis: a step toward personalized medicine. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2025.06.010

BibTeX
@article{Santos2025,
  author = {Santos, Gabrielle M and David, Paula and Hen, Or and Ontiveros-Austria, Juan Luis and Liran, Rotem and Rodriguez-Rodriguez, Sergio and Cerchiari de Godói, Julia and Patt, Yonatan Shneor and Beladev, Shaked and Okazaki, Erica and Collela, Marina and Stefanello, Bianca and Yamaguti-Hayakawa, Gabriela G and Rothschild, Cynthia and Annichino-Bizzachi, Joyce and Vargas-Ruiz, Angel and Prestes, Paula and Rocha, Vanderson and de Paula, Erich V and Gendelman, Omer and Salomon, Ophira and Demichelis-Gomez, Roberta and Barrera-Vargas, Ana and Amital, Howard and Villaça, Paula and Shoenfeld, Yehuda and Orsi, Fernanda A},
  title = {Identification of phenotypes in thrombotic primary antiphospholipid syndrome using cluster analysis: a step toward personalized medicine},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  doi = {10.1016/j.jtha.2025.06.010}
}
Kostenlos starten →